Brooke Glessing, MD
Gastroenterology · Cleveland, OHNPI 1447499819
Payments from drug & device makers
Across 87 payments — averaging $243.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$15K
- US Endoscopy$3K
- Apollo Endosurgery US Inc$1K
- ERBE USA Inc$290
- AbbVie$274
- Phathom Pharmaceuticals, Inc.$145
- plus $756 from 13 others
What the payments were for
- Consulting fees$3,25015%
- Speaking & faculty fees$10,62550%
- Travel & lodging$3,77318%
- Food & beverage$3,52217%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 42 | $15,255 |
| US Endoscopy | 3 | $3,250 |
| Apollo Endosurgery US Inc | 5 | $1,200 |
| ERBE USA Inc | 3 | $290 |
| AbbVie(2 entities) | 9 | $274 |
| Phathom Pharmaceuticals, Inc. | 2 | $145 |
| Aimmune Therapeutics, Inc. | 2 | $138 |
| Cook Medical LLC | 1 | $134 |
| Vivus LLC | 5 | $104 |
| Steris Corporation | 1 | $90 |
| Pfizer | 5 | $84 |
| Madrigal Pharmaceuticals | 2 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Organon | 1 | $25 |
| Johnson & Johnson | 1 | $21 |
| UCB, Inc. | 1 | $18 |
| Sandoz | 1 | $17 |
| Mauna Kea Technologies, Inc. | 1 | $17 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AXIOS$1,824
- GENERAL ENDOCHOICE$1,290
- OverStitch Endoscopic Suturing System$1,046
- EXALT Model D$511
- RX Cholangiogram Kit$144
- ECHOTIP INSIGHT$134
- LINZESS$125
- ZENPEP$125
- VOQUEZNA$125
- OverStitch NXT Endoscopic Suturing System$107
- VIO3 APC3$100
How this compares
$21,170 in reported general payments places this provider in the 80th percentile of 657 gastroenterology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CholestyramineCholestyramine (With Sugar) | 14 | $955 |
| Pantoprazole Sodium | 36 | $572 |
| Omeprazole | 16 | $313 |
| Dicyclomine Hcl | 16 | $278 |
| Ondansetron Hcl | 13 | $8 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Cleveland
- Florian RiederCleveland$8.7M
- Pierre GholamCleveland$1.9M
- Benjamin CohenCleveland$1.9M
- Bret LashnerCleveland$628K
- Jeffry KatzCleveland$602K
- Samita GargCleveland$470K
- Stanley CohenCleveland$382K
- Katherine FalloonCleveland$339K
- Mazen IssaCleveland$329K
- Taha QaziCleveland$307K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.